青少年1型糖尿病患者视网膜病变筛查的最佳频率:基于30年数据的马尔可夫模型研究
研究基于1990至2019年2063例接受两次以上筛查的1型糖尿病青少年的前瞻性数据,用马尔可夫链模型计算视网膜病变(DR)状态转移概率与风险比。结果显示,无DR且病程短者3年内进展至中度非增殖性DR或更差的比例较低,支持对此类青少年降低筛查频率;HbA1c升高显著加速DR进展。
要点
- 无DR者3年内进展至中度非增殖性DR或更差的比例为1.3%,支持减少筛查频率。
- 当前HbA1c每升高1%,从无DR进展至轻度非增殖性DR的风险比为1.23(95%CI 1.16-1.31)。
- 仅HbA1c可解释无DR至中度非增殖性DR或更差转移的27%,加入糖尿病病程后升至31%(P=0.03)。
核心结论
- 研究结果支持对无DR且病程短的1型糖尿病青少年降低DR筛查频率。
- 尽管DR进展至晚期通常缓慢,但较高的HbA1c会大幅加速其进展。
研究设计与样本
- 前瞻性收集1990年至2019年间至少接受两次筛查的2063例1型糖尿病青少年的数据。
- 基线年龄为13.3±1.8岁,HbA1c为8.6±1.3%(70.1±14.7 mmol/mol),糖尿病病程为5.6±2.8年,随访时间为4.8±2.8年。
- DR由7视野视网膜照片按早期治疗糖尿病视网膜病变研究(ETDRS)量表人工分级。
- 使用马尔可夫链计算DR随时间变化的概率及DR分期转移的风险比(HR)。
主要发现
- 中度非增殖性DR(MNPDR)或更差的发生率为8.6/1000患者年。
- 间隔3年后进展至MNPDR或更差的概率分别为:无DR者1.3%,极轻度DR者5.1%,轻度DR者22.2%。
- 当前HbA1c每升高1%的转移HR(95%CI)为:无DR至极轻度非增殖性DR 1.23(1.16-1.31),极轻度至轻度非增殖性DR 1.12(1.03-1.23),轻度至MNPDR或更差1.28(1.13-1.46)。
- 仅HbA1c可解释无视网膜病变与MNPDR或更差之间转移的27%,模型加入糖尿病病程后该值升至31%(P=0.03)。
- 女性及达到更高年龄也增加风险。
临床怎么用
- 原文未据此给出推荐。
- 作者认为,研究结果支持对无DR且病程短的1型糖尿病青少年降低DR筛查频率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current guidelines recommend biennial diabetic retinopathy (DR) screening commencing at the age of 11 years and after 2-5 years' duration of type 1 diabetes. Growing evidence suggests less frequent screening may be feasible. RESEARCH DESIGN AND METHODS: Prospective data were collected from 2,063 youth with type 1 diabetes who were screened two or more times between 1990 and 2019. Baseline (mean ± SD) age was 13.3 ± 1.8 years, HbA1c was 8.6 ± 1.3% (70.1 ± 14.7 mmol/mol), diabetes duration was 5.6 ± 2.8 years, and follow-up time was 4.8 ± 2.8 years. DR was manually graded from 7-field retinal photographs using the Early Treatment Diabetic Retinopathy Study (ETDRS) scale. Markov chain was used to calculate probabilities of DR change over time and hazard ratio (HR) of DR stage transition. RESULTS: The incidence of moderate nonproliferative DR (MNPDR) or worse was 8.6 per 1,000 patient-years. Probabilities of transition to this state after a 3-year interval were from no DR, 1.3%; from minimal DR, 5.1%; and from mild DR, 22.2%, respectively. HRs (95% CIs) for transition per 1% current HbA1c increase were 1.23 (1.16-1.31) from no DR to minimal NPDR, 1.12 (1.03-1.23) from minimal to mild NPDR, and 1.28 (1.13-1.46) from mild to MNPDR or worse. HbA1c alone explained 27% of the transitions between no retinopathy and MNPDR or worse. The addition of diabetes duration into the model increased this value to 31% (P = 0.03). Risk was also increased by female sex and higher attained age. CONCLUSIONS: These results support less frequent DR screening in youth with type 1 diabetes without DR and short duration. Although DR progression to advanced stages is generally slow, higher HbA1c greatly accelerates it.
引用
- Januszewski AS, Velayutham V, Benitez-Aguirre PZ, et al. Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes: Markov Modeling Approach Based on 30 Years of Data. Diabetes Care. 2022. PMID: 35975939. doi:10.2337/dc22-0071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。